<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00978978</url>
  </required_header>
  <id_info>
    <org_study_id>SOR484909CTIL</org_study_id>
    <nct_id>NCT00978978</nct_id>
  </id_info>
  <brief_title>Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver Disease</brief_title>
  <official_title>Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soroka University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized-controlled trial (RCT) comparing the use of Propofol and traditional
      sedation (Midazolam and Fentanyl) for diagnostic and screening endoscopies in patients with
      liver diseases. The investigators' working hypothesis is that the use of propofol will be
      translated in a shorter recovery and discharge times with a higher patient satisfaction and a
      decrease in general complications in the context of patients with advanced liver disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and efficacy of propofol in liver diseases</measure>
    <time_frame>At the end of each endoscopy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Propofol, endoscopies, liver diseases</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol, endoscopies, liver diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>midazolam and fentanyl, endoscopies, liver diseases</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control: midazolam and fentanyl, endoscopies, liver diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol VS. midazolam and fentanyl, endoscopies, liver diseases</intervention_name>
    <description>Intervention group (Propofol): It will be administered as a monotherapy under direct gastroenterologists'
Control group (Midazolam with or without Fentanyl): Both drugs will be administered by the gastroenterologists</description>
    <arm_group_label>Propofol, endoscopies, liver diseases</arm_group_label>
    <arm_group_label>midazolam and fentanyl, endoscopies, liver diseases</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients older than 18 and younger than 75 years with advanced liver
             disease, defined by the presence of liver fibrosis at least F3 and higher in the
             METAVIR score or with established cirrhosis (Child Pugh A, B and C)

        Exclusion Criteria:

          -  Patients with significant cardiorespiratory disease i.e. advanced respiratory, renal
             and heart failure (ASA class III or higher except for patients with decompensate liver
             cirrhosis), obstructive sleep apnea or those with mild degree of liver fibrosis (less
             than F3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jorge-Shmuel Delgado, MD</last_name>
    <phone>972-8-6403164</phone>
    <email>delgado@bgu.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology. Soroka University Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge-Shmuel Delgado, MD</last_name>
      <email>delgado@bgu.ac.il</email>
    </contact>
    <investigator>
      <last_name>Jorge-Shmuel Delgado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <last_update_submitted>October 11, 2009</last_update_submitted>
  <last_update_submitted_qc>October 11, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jorge-Shmuel Delgado, MD.</name_title>
    <organization>Department of Gastroenterology &amp; Hepatology. Soroka University Medical Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

